J
Josep M. Antó
Researcher at Pompeu Fabra University
Publications - 523
Citations - 45951
Josep M. Antó is an academic researcher from Pompeu Fabra University. The author has contributed to research in topics: Asthma & Population. The author has an hindex of 100, co-authored 493 publications receiving 38663 citations. Previous affiliations of Josep M. Antó include University of Rochester & Centra.
Papers
More filters
Journal ArticleDOI
Fast and slow health crises of Homo urbanicus: loss of resilience in communicable diseases, like COVID-19, and non-communicable diseases
TL;DR: It is good news that the COVID-19 pandemic may mean an uprise of evidence-based science and factful information in the modern time of “post-truth,” and it is becoming of outmost importance to make a difference between the true truth and the fake truth.
Proceedings ArticleDOI
Mortality prediction in chronic obstructive pulmonary disease comparing the GOLD 2015 and GOLD 2019 staging systems: a pooled analysis of individual patient data
Elena García Castillo,Tamara Alonso Pérez,Julio Ancochea Bermúdez,Maria Teresa Pastor Sanz,Juan P. de Torres,Bernd Lamprecht,Pere Almagro,Pablo Martínez Camblor,Marc Miratvilles,Mónica Rodríguez Carballeira,Inmaculada Alfageme,Ana Sofía Ramirez Garcia-Luna,Berhand Kaiser,Ciro Casanova,Cristóbal Esteban,Juan José Soler Cataluña,Bartolome Celi,Jose M. Marin,Patricia Sobradillo,Peter Lange,Judith Garcia Aymerich,Josep M. Antó,Alice M Turner,Han Meilan,Arnulf Laghammer,Sigrid Anna Vikjord,Alice Stenberg,Linda Leivseth,Ane Johannessen,Oga Toru,Borja G. Cosío,Andrés L. Echazarreta,Nicolas Roche,Pierre-Régis Burgel,Don D. Sin,Milo A. Puhan,José Luis López Campos,Annie Navarro,Laura Carrasco,Per Bakke,Joan B. Soriano +40 more
TL;DR: This study studied 17 139 COPD patients from the 3CIA study, selecting those with complete data and compared the predictive ability for 5-year mortality of both classifications.
Journal ArticleDOI
Asociación entre el cociente FEF25-75%/FVC y la hiperreactividad bronquial
Isabel Urrutia,Alberto Capelastegui,José M. Quintana,Nerea Muniozguren,Félix Payo,J. Martínez Moratalla,José Antonio Maldonado,X. Basagana,Josep M. Antó,Jordi Sunyer +9 more
TL;DR: El cociente FEF25-75%/FVC esta asociado significativamente a the HRB, independientemente of la edad, the existencia of atopia, el consumo of tabaco, el area geografica, los sintomas respiratorios y el volumen espiratorio forzado in el primer segundo.
Journal ArticleDOI
Allergen immunotherapy in MASK‐air users in real‐life: Results of a Bayesian mixed‐effects model
Bernardo Sousa-Pinto,Luís Filipe Azevedo,Ana Sá-Sousa,R. J. Vieira,Rita Amaral,Ludger Klimek,Wienczyslawa Czarlewski,Josep M. Antó,Anna Bedbrook,Violeta Kvedariene,Maria Teresa Ventura,Ignacio J. Ansotegui,Karl E. Bergmann,Luisa Brussino,G. Walter Canonica,Victoria Cardona,Pedro Carreiro-Martins,Thomas B. Casale,Lorenzo Cecchi,Tomas Chivato,Derek K. Chu,Cemal Cingi,Elísio Costa,Alvaro A. Cruz,G. De Feo,Philippe Devillier,Wytske Fokkens,Mina Gaga,Bilun Gemicioglu,Tari Haahtela,Juan Carlos Ivancevich,Zhanat Ispayeva,Marek Jutel,Piotr Kuna,Igor Kaidashev,Helga Kraxner,Désirée Larenas-Linnemann,Daniel Laune,Brian J. Lipworth,Renaud Louis,Michael Makris,Riccardo Monti,M. Morais-Almeida,Ralph Mösges,Joaquim Mullol,Mikaela Odemyr,Yoshitaka Okamoto,Nikolaos G. Papadopoulos,Vincenzo Patella,Nhân Pham-Thi,Frederico S. Regateiro,Sietze Reitsma,Philip W. Rouadi,Bolesław Samoliński,Milan Sova,Ana Todo-Bom,Luís Taborda-Barata,Peter Valentin Tomazic,Sanna Toppila-Salmi,Joaquín Sastre,Ioanna Tsiligianni,Arunas Valiulis,Dana Wallace,Susan Waserman,Arzu Yorgancioglu,Mihaela Zidarn,Torsten Zuberbier,João Fonseca,Jean Bousquet,Oliver Pfaar +69 more
TL;DR: In patients with grass pollen allergy, SLIT‐tablet, when compared to no AIT and to SCIT, is associated with lower reported symptom severity, and future longitudinal studies following internationally‐harmonised standards for performing and reporting real‐world data in AIT are needed to better understand its ‘real‐world’ effectiveness.
Journal ArticleDOI
Low serum DHEA-S is associated with impaired lung function in women.
Giancarlo Pesce,Kai Triebner,Diana A van der Plaat,Dominique Courbon,Steinar Hustad,Torben Sigsgaard,Dennis Nowak,Joachim Heinrich,Josep M. Antó,Sandra Dorado-Arenas,Jesús Martínez-Moratalla,Jose Antonio Gullón-Blanco,José Luis Sánchez-Ramos,Chantal Raherison,Isabelle Pin,Pascal Demoly,Thorarinn Gislason,Kjell Torén,Bertil Forsberg,Eva Lindberg,Elisabeth Zemp,Elisabeth Zemp,Rain Jõgi,Nicole Probst-Hensch,Nicole Probst-Hensch,Shyamali C. Dharmage,Deborah Jarvis,Judith Garcia-Aymerich,Alessandro Marcon,Francisco Gómez-Real,Francisco Gómez-Real,Bénédicte Leynaert,Bénédicte Leynaert +32 more
TL;DR: Low DHEA-S levels in women were associated with impaired lung function and a greater risk of developing airflow limitation later in adult life, providing new evidence supporting a role of DHEa-S in respiratory health.